Harald Hefter Selected Research

Harald Hefter Research Topics

Disease

21	Torticollis (Wryneck) 12/2023 - 01/2011
14	Hepatolenticular Degeneration (Wilson's Disease) 07/2023 - 12/2002
6	Pain (Aches) 01/2020 - 11/2006
6	Tremor (Tremors) 01/2020 - 04/2006
5	Stroke (Strokes) 03/2021 - 08/2005
4	Dystonia (Limb Dystonia) 12/2023 - 01/2010
3	Disease Progression 10/2023 - 04/2006
3	Liver Diseases (Liver Disease) 07/2023 - 12/2002
3	Muscle Spasticity (Spastic) 03/2021 - 09/2012
2	Paralysis (Palsy) 11/2022 - 01/2019
2	Peroneal Neuropathies 03/2021 - 01/2021
2	Myofascial Pain Syndromes (Myofascial Pain Syndrome) 11/2011 - 11/2006
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2006 - 02/2003
1	Meige Syndrome 12/2023
1	Dystonic Disorders (Writer's Cramp) 10/2023
1	Rare Diseases (Rare Disease) 07/2022
1	Botulism 07/2022
1	Hemiplegia (Spastic Hemiplegia) 03/2021
1	Constipation 10/2020
1	Muscle Hypertonia 01/2020
1	Dysarthria (Spastic Dysarthria) 01/2018
1	Cerebellar Ataxia (Dysmetria) 10/2016
1	Paraneoplastic Polyneuropathy 10/2016
1	Multiple Myeloma 10/2016
1	Adenocarcinoma 10/2016
1	Polyneuropathies (Polyneuropathy) 10/2016
1	Neoplasms (Cancer) 10/2016
1	Contracture 02/2014
1	Neurologic Manifestations (Neurological Manifestations) 08/2013
1	Fibrosis (Cirrhosis) 01/2012
1	Ganglion Cysts (Ganglion) 01/2012
1	Hypertrophy 01/2011
1	Anemia 02/2007
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 04/2006
1	Paresis (Hemiparesis) 08/2005
1	Parkinson Disease (Parkinson's Disease) 09/2004
1	Atherosclerosis 09/2004
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2004
1	Iron Overload 12/2002

Drug/Important Bio-Agent (IBA)

19	Botulinum Toxins (Botulinum Toxin)IBA 10/2023 - 08/2005
16	incobotulinumtoxinA FDA Link 01/2023 - 11/2006
12	Type A Botulinum Toxins (Botox)FDA Link 01/2023 - 01/2011
10	CopperIBA 07/2023 - 12/2002
7	Neutralizing AntibodiesIBA 10/2023 - 09/2016
5	abobotulinumtoxinA FDA Link 01/2020 - 11/2006
2	ButyrylcholinesteraseIBA 11/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2022
2	onabotulinum toxin AIBA 11/2022 - 01/2020
2	Ceruloplasmin (Ferroxidase)IBA 01/2018 - 04/2006
2	Pain-FreeIBA 11/2011 - 11/2006
1	AntidotesIBA 07/2022
1	Cholinesterases (Cholinesterase)IBA 01/2022
1	Polymethyl Methacrylate (Sol)IBA 03/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	rimabotulinumtoxinB FDA Link 10/2020
1	EnzymesIBA 01/2018
1	AutoantibodiesIBA 10/2016
1	Inositol 1,4,5-Trisphosphate Receptors (Inositol Triphosphate Receptor)IBA 10/2016
1	Immunoglobulin G (IgG)IBA 10/2016
1	Trientine (Trien)FDA Link 08/2013
1	Chelating AgentsIBA 08/2013
1	Penicillamine (Cuprimine)FDA Link 08/2013
1	Retinaldehyde (Retinal)IBA 01/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2010
1	Primidone (Sertan)FDA LinkGeneric 01/2010
1	PhosphatidylserinesIBA 02/2007
1	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 02/2007
1	CeramidesIBA 02/2007
1	AcidsIBA 02/2007
1	Dihydrotachysterol (AT 10)IBA 11/2006
1	Methionine (L-Methionine)FDA Link 04/2006
1	Codon (Codons)IBA 04/2006
1	Prion ProteinsIBA 04/2006
1	NeurotoxinsIBA 09/2004
1	Levodopa (L Dopa)FDA LinkGeneric 09/2004
1	ManganeseIBA 02/2003
1	Transferrin (beta 2 Transferrin)IBA 12/2002
1	Ferritins (Ferritin)IBA 12/2002
1	IronIBA 12/2002

Therapy/Procedure

21	Therapeutics 12/2023 - 01/2011
12	Injections 12/2023 - 11/2006
3	Intramuscular Injections 01/2023 - 01/2011
3	Aftercare (After-Treatment) 01/2021 - 11/2006
2	Liver Transplantation 07/2023 - 01/2022
2	Chelation Therapy (Therapy, Chelation) 07/2023 - 12/2002
1	Duration of Therapy 01/2018
1	Occupational Therapy (Therapy, Occupational) 02/2014